論文 - 岡村　智教

Long-term cardiovascular mortality risk of hyperuricemia and chronic kidney disease in a general Japanese population: NIPPON DATA90

Ono K., Hirata A., Kadota A., Harada A., Nakamura Y., Hayakawa T., Takashima N., Fujiyoshi A., Kita Y., Ohkubo T., Okayama A., Miura K., Okamura T.

Endocrine 91 （ 1 ）  2026年12月

ISSN  1355008X

　概要を見る

Purpose: Whether hyperuricemia (HU) independently predicts cardiovascular disease (CVD) remains debated, whereas chronic kidney disease (CKD) is a well-established risk factor. This study assessed the independent and mediated association of HU in CKD on long-term CVD mortality in a 30-year nationwide Japanese cohort. Methods: Data from NIPPON DATA90 participants aged ≥ 30 years enrolled in 1990 and followed for up to 30 years were used. HU was defined as serum uric acid ≥ 416.4 µmol/L, and CKD as an estimated glomerular filtration rate < 60 mL/min/1.73 m² or positive proteinuria. Four baseline categories were created (neither, HU-only, CKD-only, both conditions), and analyzed via Cox models to estimate hazard ratios (HR) for CVD mortality, adjusted for age, sex, hypertension, diabetes mellitus, dyslipidemia, BMI, and history of smoking/alcohol. Results: Among 7,336 participants (58.5% women; mean age 52.5 years), 807 CVD deaths occurred over a mean 24.2 years. At baseline, 86.6% had neither condition, 4.9% HU-only, 7.1% CKD-only, and 1.5% both. HU-only was not significantly associated with CVD mortality (HR 1.14, 0.81–1.61), CKD-only had significant association (1.28, 1.04–1.59), and both HU/CKD conditions had the highest risk (2.18, 1.50–3.18). Further analyses showed that HU-only was significant in women (2.44, 1.13–5.28) but not men (1.04, 0.71–1.52). Conclusion: Overall, CKD and coexistent HU/CKD showed to be a significant CVD mortality risk, and HU’s association with CVD mortality may be partly mediated through CKD. This study observed that HU and CKD coexistence heighten the risk of CVD mortality. Integrated management of serum urate and renal health may aid long-term CVD prevention.

• Access to Document (DOI)

Effect of population-approach programs promoting salt reduction and potassium intake in Japan: the Population-based Sodium/Potassium Improvement Program (PoSPIP).

Hisamatsu T, Kinuta M, Ohkubo T, Tsuchihashi T, Yoshita K, Takemi Y, Hayabuchi H, Okami Y, Kitaoka K, Sakaguchi K, Hozawa A, Okamura T, Itoh H, Rakugi H, Node K, Miura K, PoSPIP Research Group

Hypertension research : official journal of the Japanese Society of Hypertension 2026年05月

ISSN  0916-9636

• Access to Document (DOI)

Effect of population-approach programs promoting salt reduction and potassium intake in Japan: the Population-based Sodium/Potassium Improvement Program (PoSPIP).

Hisamatsu T, Kinuta M, Ohkubo T, Tsuchihashi T, Yoshita K, Takemi Y, Hayabuchi H, Okami Y, Kitaoka K, Sakaguchi K, Hozawa A, Okamura T, Itoh H, Rakugi H, Node K, Miura K, PoSPIP Research Group

Hypertension research : official journal of the Japanese Society of Hypertension 2026年05月

ISSN  0916-9636

• Access to Document (DOI)

Seasonal BMI Amplitude and Risk of Kidney Function Decline in Japanese Adults With Type 2 Diabetes (JDDM 82).

Toki R, Sakamoto M, Yuki M, Iida M, Yamazaki M, Ichikawa S, Horiuchi R, Maegawa H, Okamura T, Takebayashi T

Diabetes care 49 （ 6 ） 990 - 998 2026年04月

ISSN  0149-5992

　概要を見る

OBJECTIVE: Body weight variability is linked to cardiometabolic outcomes, but its renal impact in type 2 diabetes remains uncertain. We tested whether the magnitude of seasonal BMI fluctuation is independently associated with kidney function decline. RESEARCH DESIGN AND METHODS: We analyzed a nationwide, multicenter Japanese cohort (2014-2020). Monthly BMI was modeled using seasonal-trend locally estimated scatterplot smoothing to quantify each participant's within-year peak-to-trough difference. The primary outcome was ≥40% decline in estimated glomerular filtration rate (eGFR). Secondary outcomes were ≥30% eGFR decline, creatinine doubling, incident chronic kidney disease (CKD) stage ≥3, and kidney failure. Associations were estimated using multivariable Cox models with clinic as a random effect. RESULTS: Among 6,700 outpatients (median follow-up: 6.8 years), 779 reached the primary end point. Each 1-SD increase in BMI fluctuation was associated with higher risk of ≥40% eGFR decline (hazard ratio [HR] 1.23, 95% CI 1.16-1.31). The highest versus lowest tertile showed a 1.7-fold increased risk (HR 1.72, 95% CI 1.42-2.09). Patterns were consistent for ≥30% eGFR decline (HR 1.18, 95% CI 1.13-1.23), creatinine doubling (HR 1.30, 95% CI 1.17-1.45), and incident CKD stage ≥3 (HR 1.11, 95% CI 1.07-1.16). Longitudinal analyses showed steeper eGFR decline in the highest-fluctuation group. Results were robust across sensitivity analyses, including models for time-varying medication exposure. CONCLUSIONS: In type 2 diabetes, larger intra-annual BMI fluctuations were independently and dose-dependently associated with kidney function decline. Seasonal BMI amplitude may identify higher-risk individuals; whether reducing seasonal BMI fluctuations improves kidney outcomes warrants prospective evaluation.

• Access to Document (DOI)

Are changes in the urinary sodium-to-potassium ratio associated with changes in blood pressure in a healthy population with low urinary sodium-to-potassium ratios? Eight-year follow-up results from the KOBE Study.

Kawahara M, Tsukinoki R, Miyamatsu N, Kuwabara K, Kubo S, Kubota Y, Higashiyama A, Hirata A, Hirata T, Miyazaki J, Sugiyama D, Miyamoto Y, Okamura T

Hypertension research : official journal of the Japanese Society of Hypertension 2026年04月

ISSN  0916-9636

　概要を見る

Little is known about the associations between changes in the urinary sodium-to-potassium (Na/K) ratio and blood pressure (BP) in healthy individuals. Using survey data, urinary data, and BP data from the KOBE Study, this longitudinal study aimed to assess the associations between changes in the urinary Na/K ratio and BP in a healthy Japanese population over an 8-year follow-up period. We analyzed 567 participants aged 40–74 years who did not initiate antihypertensive or cardiovascular disease treatment during follow-up. Changes in the spot urinary Na/K ratio and BP were calculated by subtracting the baseline values from the follow-up measurements, and their associations were examined using a multivariable linear regression analysis that adjusted for sex, age, body mass index, baseline Na/K ratio and BP, low-density lipoprotein, hemoglobin A1c, ethanol intake, smoking status, salt taste sensitivity, years of education, employment status, baseline survey season, and 8-year follow-up survey season. The study cohort had a mean spot urinary Na/K ratio of 2.1 at baseline. While BP increased significantly over the 8-year follow-up period, the urinary Na/K ratio remained unchanged. However, urinary Na/K ratio changes were positively associated with changes in systolic BP (β = 1.48, p = 0.001) and diastolic BP (β = 0.76, p = 0.004). In conclusion, increases in spot urinary Na/K ratios were predictive of long-term BP elevation in a healthy, normotensive population with near-optimal urinary Na/K ratios at baseline. These findings indicate that maintaining a low urinary Na/K ratio is important for BP control, even among healthy individuals. (Figure presented.)

• Access to Document (DOI)

Cardiovascular Risk of Alcohol Consumption due to Renal Impairment: A 10-Year Prospective Study in a Community-Dwelling Japanese Population

Hirata, A; Harada, S; Iida, M; Matsumoto, M; Miyagawa, N; Toki, R; Edagawa, S; Shibuki, T; Kuwabara, K; Kohsaka, S; Izawa, Y; Sawano, M; Takizawa, T; Shoji, S; Katsumata, M; Sugiyama, D; Okamura, T; Takebayashi, T

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 33 （ 6 ） 775 - 797 2026年03月

ISSN  1340-3478

• Access to Document (DOI)

Associations between Mobile Health Applications and Blood Pressure among Non-Patient Adults: A Systematic Review and Meta-Analysis.

Li Q, Ikeda A, Charvat H, Ohira T, Muraki I, Okamura T, Sato S, Miura M, Kamijima J, Ikeda S, Yamagishi K, Tanigawa T

American journal of hypertension 2026年02月

ISSN  0895-7061

• Access to Document (DOI)

Independent and combined associations of body mass index and visceral fat area with kidney function decline in a healthy Japanese urban population: a longitudinal study.

Enami MS, Hirata A, Kuwabara K, Miyazaki J, Kubota Y, Nishida Y, Kubo S, Hirata T, Uchida T, Kadota A, Higashiyama A, Sugiyama D, Nishikawa T, Miyamatsu N, Miyamoto Y, Okamura T

BMC nephrology 27 （ 1 ） 96 2026年01月

　概要を見る

Background: Obesity has been linked to progressive loss of kidney function, but the independent and combined associations of body mass index (BMI) and visceral fat accumulation remain uncertain in healthy individuals. This study aimed to clarify the longitudinal relationship between BMI, visceral fat area (VFA), and chronic kidney disease (CKD), defined as an estimated glomerular filtration rate based on serum cystatin C (eGFRcys) < 60 mL/min/1.73 m² among the Kobe Study participants targeting healthy urban residents in Japan. Methods: A total of 897 participants (267 men, 630 women) without CKD and with a mean age of 61.4 years were analyzed. VFA was measured using the impedance method, and participants were followed for a median of 8.3 years. Participants were classified into four groups based on baseline BMI (kg/m²) and VFA (cm²): G1 (VFA < 100 and BMI < 25), G2 (VFA < 100 and BMI ≥ 25), G3 (VFA ≥ 100 and BMI < 25), G4 (VFA ≥ 100 and BMI ≥ 25). Multivariable linear regression models were used to estimate adjusted mean annual changes in eGFRcys, and Cox proportional hazards models were applied to calculate hazard ratios (HRs) for incident CKD, adjusting for potential confounders (age, sex, smoking status, alcohol consumption, dyslipidemia, diabetes, hypertension and eGFRcys at baseline). Results: During follow-up, 85 participants (9.5%) developed CKD. The adjusted mean annual decline in eGFRcys was − 2.17% in G1, − 3.29% in G2, − 2.81% in G3, and − 3.81% in G4. Compared with G1, both G3 and G4 showed an elevated risks of CKD incidence (G3: HR 2.40, 95% CI 1.14–5.05; G4: HR 3.89, 95% CI 2.17–6.98), whereas the confidence interval crossed 1 for G2 (HR 0.88, 95% CI 0.12–6.47). Participants in G4 exhibited the steepest decline in kidney function and the highest CKD incidence rate (49.2 per 1,000 person-years). Conclusions: In healthy adults, the combination of elevated BMI and VFA was associated with accelerated kidney function decline. These findings underscore the importance of evaluating visceral fat in addition to BMI for early identification of individuals at increased risk of CKD and enable preventive strategies. Clinical trial number: Not applicable.

• Access to Document (DOI)

The Japanese Society of Hypertension Guidelines for blood pressure control using digital technologies

Arima H., Itoh H., Ohkubo T., Ohya Y., Kabayama M., Kishi T., Hirawa N., Miura K., Miura S.I., Yamamoto K., Yoshimura C., Rakugi H., Asayama K., Inoue T., Ohishi M., Kusaka M., Goto K., Shimosawa T., Nishiyama A., Hoshide S., Yano Y., Kaneko K., Uesugi F., Shigyo M., Suenaga E., Masujima T., Kawachi S., Okayama A., Miyakawa M., Miyamatsu N., Nakamura K., Saito I., Murakami Y., Ishida M., Kitagawa K., Ohnishi H., Okada H., Fujioka Y., Ogawa Y., Shide K., Inoue S., Naito Y., Tsukahara T., Kakuma T., Yoshida M., Takashima N., Yagita Y., Kuwabara M., Takahashi K., Hozawa A., Eguchi H., Mogi M., Metoki H., Mukoyama M., Mizuno A., Furuhashi M., Fujiyoshi A., Higashi Y., Node K., Toyoda K., Tsuchihashi T., Tamura K., Takemi Y., Sugawara A., Shibata H., Shibata S., Koriyama H., Kario K., Katsuya T., Kai H., Ogura S., Okamura T., Uehara Y., Ichihar A., yamashita S., hosoki S., satoh A., sakamoto Y., koyoshi R., maeda T., Yamazato M., Mori F., Fujii T., Haze T., Niijima T., Sakaguchi T., Kobayashi Y., Kitajima K., Akasaki Y., Akagi Y., Sakima A., Yoshida S., Yamanokuchi T., Morito N., Fujimoto T., Hirata T., Tada K., Takami Y., Takahashi K., Segawa H.

Hypertension Research 49 （ 4 ） 1087 - 1123 2026年

ISSN  09169636

• Access to Document (DOI)

Serum total apoptosis inhibitor of macrophage, metabolomic signatures, and incident dyslipidemia: A population-based prospective study

Toki R., Harada S., Arai S., Hirata A., Iida M., Miyagawa N., Edagawa S., Ishikawa T., Hirayama A., Sugimoto M., Okamura T., Miyazaki T., Takebayashi T.

Journal of Clinical Lipidology 20 （ 4 ） 806 - 816 2026年

ISSN  19332874

　概要を見る

BACKGROUND The role of the apoptosis inhibitor of macrophages (AIM) in human lipid metabolism remains unclear. OBJECTIVE This study aimed to investigate the cross-sectional associations between serum AIM and plasma metabolites and to determine if baseline AIM concentrations predict incident dyslipidemia. METHODS This study used a community-based cohort of 3139 participants for cross-sectional metabolomic analysis. Among them, 1292 participants without dyslipidemia at baseline were followed prospectively for up to 8.5 years. Cox proportional hazards models were used to estimate hazard ratios for incident high low-density lipoprotein cholesterol and metabolic dyslipidemia (high triglycerides and/or low high-density lipoprotein cholesterol [HDL-C]) across AIM tertiles. RESULTS Cross-sectionally, higher AIM concentrations were associated with elevated acylcarnitines and tricarboxylic acid cycle intermediates. Longitudinally, higher baseline AIM was associated with an increased risk of developing metabolic dyslipidemia in women (highest vs lowest tertile hazard ratio, 1.84) and showed a similar but smaller nonsignificant trend in men. The risk for high low-density lipoprotein cholesterol was significantly increased in women but not in men. These associations remained robust after multivariable adjustment. CONCLUSION Elevated baseline AIM concentrations were prospectively associated with the development of metabolic dyslipidemia in women, with a similar but nonsignificant trend in men, and with high LDL-C in women. The related metabolomic profile suggests enhanced lipolysis and altered lipid metabolism. Therefore, AIM may serve as a biomarker for future dyslipidemia, particularly for triglyceride and HDL-C dysregulation.

• Access to Document (DOI)

[Development of quality management checklists for medical facilities conducting workplace cancer screening programs].

Okada Y, Saika K, Tatemichi M, Okamura T, Saitoh E

Sangyo eiseigaku zasshi = Journal of occupational health 68 （ 2 ） 65 - 77 2025年12月

ISSN  1341-0725

• Access to Document (DOI)

Longitudinal study of plasma metabolites during menopause and their associations with later onset of metabolic syndrome.

Miyake A, Iida M, Harada S, Sugiyama D, Matsumoto M, Miyagawa N, Toki R, Edagawa S, Hirata A, Kuwabara K, Okamura T, Sato A, Amano K, Hirayama A, Sugimoto M, Soga T, Tomita M, Arakawa K, Kisu I, Yamagami W, Takebayashi T

The Journal of clinical endocrinology and metabolism 111 （ 6 ） e1672 - e1680 2025年12月

ISSN  0021-972X

　概要を見る

Context: Previous metabolomics studies suggest potential associations between menopausal changes in lipids and an increased risk of metabolic syndrome (MetS). However, longitudinal data on other key metabolites, such as branched-chain amino acids (BCAAs) and homocysteine, remain limited, and most studies lack long-term follow-up across the menopause transition. Objective: This study aimed to investigate longitudinal changes in circulating metabolites during menopause over a mean follow-up of 5 years and assess their associations with subsequent MetS development. Methods: Premenopausal women from the Tsuruoka Metabolomics Cohort Study who participated in at least one follow-up survey were included. Menopausal status, data on MetS, and plasma metabolites profiled using capillary electrophoresis mass spectrometry were assessed at each visit. Thirty-one metabolites were examined for associations with menopausal status using mixed-effects models. The association of these menopause-related metabolites with MetS development was examined via logistic regression analysis adjusted for follow-up duration. Results: Among 953 women (aged 43.8 ± 5.4 years), 316 (33.2%) reached menopause during follow-up (5.0 ± 1.1 years). Eighteen metabolites changed significantly with menopause, particularly those related to BCAA metabolism, urea cycle, and homocysteine metabolism. Of 695 women without MetS at baseline, 65 (9.4%) developed MetS. Glutamate (odds ratio [95% CI]: 1.95 [1.49-2.57]) was associated with higher MetS risk. Higher levels of glutamate, valine, leucine, and cystine were significantly associated with the development of hyperglycemia. Conclusion: Longitudinal changes in charged metabolites occur across the menopausal transition, with specific metabolites such as glutamate possibly contributing to the metabolic alterations underlying increased MetS risk.

• Access to Document (DOI)

Current Status of Cardiovascular Disease in Japan: Prevention Strategies, Future Challenges, and Fundamental Lessons

Okamura T., Hirata A.

Journal of the American College of Cardiology 86 （ 22 ） 2106 - 2108 2025年12月

ISSN  07351097

• Access to Document (DOI)

Association of repeated high serum osmolarity with cognitive function in older Japanese adults in a KOBE study subanalysis

Nishikawa T., Miyamatsu N., Higashiyama A., Kubota Y., Nishida Y., Hirata T., Hirata A., Miyazaki J., Tatsumi Y., Sugiyama D., Kuwabara K., Kubo S., Miyamoto Y., Okamura T.

Scientific Reports 15 （ 1 ） 36784 2025年12月

ISSN  2045-2322

　概要を見る

The relationship between serum osmolarity and cognitive function has not been fully characterized. This study aimed to examine the cross-sectional association between repeated high serum osmolarity and cognitive performance among elderly community residents. We performed a subanalysis of the Kobe Orthopedic and Biomedical Epidemiological Study, including residents aged ≥ 75 years who completed the Japanese Montreal Cognitive Assessment (MoCA-J) in 2016–2017 (n = 127), 2018–2019 (n = 71), and 2020 (n = 16). Serum osmolarity was obtained from the data in the 2012–2013 survey and in the 2016–2017 survey. MoCA-J scores were dichotomized at ≤ 22 versus > 22. Multivariate logistic regression adjusted for demographic, lifestyle including daily non-alcohol drink intake, seasonal, and clinical covariates to assess associations between osmolarity status and cognitive group. Among 214 participants (mean age 76.2 ± 1.3 years; 56% female), high osmolarity (≥ 300 mOsm/L) in 2012–2013 was associated with MoCA-J ≤ 22 (OR 2.67, 95% CI 1.29–5.53, p = 0.008). A similar association emerged for 2016–2017 measurements (OR 6.12, 95% CI 1.46–25.61, p = 0.013). Participants with high serum osmolarity at both time points showed a stronger cross-sectional association with lower MoCA-J scores (OR 17.64, 95% CI = 1.8–184.83, p = 0.017). No significant association was observed between daily non-alcoholic drink (NAD) intake and either MoCA-J scores or serum osmotic pressure. Repeated high serum osmolarity was cross-sectionally associated with lower cognitive performance in Japanese community-dwelling older adults. While NAD intake showed no significant association, further research is needed to explore the potential role of serum osmolarity in cognitive health. These findings warrant confirmation in larger prospective studies.

• Access to Document (DOI)

The JSH Morning Hypertension Eradication Program Project

Kario, K; Nishiyama, A; Shibata, S; Mogi, M; Arima, H; Kishi, T; Ishida, M; Furuhashi, M; Ichihara, A; Katsuya, T; Miura, K; Miura, SI; Ohishi, M; Shibata, H; Shimosawa, T; Sugawara, A; Tamura, K; Toyoda, K; Yamamoto, K; Hoshide, S; Nakagawa, N; Tomita, H; Tanaka, A; Hozawa, A; Hatta, T; Nomura, A; Kabayama, M; Rakugi, H; Ohya, Y; Node, K; Kai, HSS; Arakawa, K; Kawarazaki, W; Okamura, T; Takemi, Y; Kaneko, H; Shinohara, K; Hirawa, N; Sakima, A; Ohkubo, T; Asayama, K; Tomitani, N

HYPERTENSION RESEARCH 48 （ 11 ） 2771 - 2780 2025年11月

ISSN  0916-9636

• Access to Document (DOI)

[Comparison of estimated salt and potassium intake and urinary sodium-to-potassium ratio based on casual urine: A 10-year follow-up of NIPPON DATA2010].

Kitaoka K, Kadota A, Yoshita K, Okami Y, Kondo K, Harada A, Okuda N, Ohkubo T, Okamura T, Miura K

[Nihon koshu eisei zasshi] Japanese journal of public health 73 （ 2 ） 139 - 146 2025年10月

ISSN  0546-1766

• Access to Document (DOI)

Low-Density-Lipoprotein Cholesterol Control and Treatment Status 1 Year after the Initial Health Checkup in Individuals with Referral-Level LDL Cholesterol.

Aoki H, Kitaoka K, Suzuki Y, Kaneko H, Okada A, Takeda N, Morita H, Hiroi Y, Node K, Furui Y, Okamura T, Miura K, Yasunaga H, Takeda N

Journal of atherosclerosis and thrombosis 33 （ 2 ） 204 - 215 2025年09月

ISSN  1340-3478

　概要を見る

Aims: Despite strong recommendations for medical consultation, the treatment status and low-density lipoprotein cholesterol (LDL-C) levels at 1-year follow-up of individuals with referral-level LDL-C identified in health checkups remain unclear. We evaluated the treatment status and 1-year LDL-C control among individuals identified in health checkups as requiring early medical consultation due to LDL-C levels of ≥ 180 mg/dL. Methods: We conducted a nationwide cohort study including health checkup data for individuals aged 20–74 years. We identified 102,049 individuals (median age: 48 years; male: 66.8%) with uncontrolled LDL-C (≥ 180 mg/dL) at baseline, who had no prior lipid-lowering therapy. Poisson regression with robust error variance was used to assess factors associated with uncontrolled LDL-C at 1 year. Results: Among individuals with LDL-C ≥ 180 mg/dL at baseline, 56,147 (55.0%) visited a medical institution within 3 months of the checkup, and 13,124 (12.9%) were prescribed lipid-lowering medications at 1 year. At 1 year follow-up, 49,260 (48.3%) still had LDL-C ≥ 180 mg/dL. Factors associated with persistent LDL-C ≥ 180 mg/dL at 1 year included obesity (RR: 1.07, [95% CI: 1.06–1.09]), 10 mg/dL increase in LDL-C at baseline (1.11 [1.10–1.11]), smoking (1.05 [1.04–1.07]), alcohol consumption (0.95 [0.94–0.97]), poor sleep quality (1.02 [1.01–1.03]), and skipping breakfast ≥ 3 times per week (1.07 [1.05–1.08]). Conclusions: Despite being classified as requiring early medical intervention, only half of individuals with LDL-C ≥ 180 mg/dL visited a physician within 3 months, and nearly half continued to have uncontrolled LDL-C at 1 year. Strategies to facilitate timely medical visits and appropriate lipid management in health checkup-identified cases are warranted.

• Access to Document (DOI)

Effectiveness of recommendations in promoting the use of Mobile health applications in health guidance: a randomized controlled trial.

Onoue T, Nishida K, Nakata Y, Hayashi F, Marutani M, Sakane N, Moriguchi J, Muto S, Kato K, Masuda I, Okamura T, Matsuzaki K, Kawamura T, Tsushita K

Journal of occupational health 67 （ 1 ）  2025年07月

ISSN  1341-9145

　概要を見る

Objectives: Use of commercially available mobile health (mHealth) applications in supporting lifestyle improvements has become popular in recent years. However, the effectiveness of advice promoting the use of such applications based on individual behavioral goals in a health guidance setting remains unclear. This study explored how guiding participants of the Specific Health Guidance (SHG) program, a Japanese public health initiative to prevent cardiovascular disease, to use commercially available mHealth applications impacted their application usage, lifestyle habits, and cardiovascular risk factors. Methods: In this multicenter, randomized, open-label, parallel-group comparison study, 156 individuals with a history of SHG participation and who were engaged in the Motivational Health Guidance program (a type of SHG) in 2021 were assigned to intervention (n = 76) or control (n = 80) groups. Whereas both groups received standard guidance, the intervention group also received recommendations for mHealth applications based on their individual behavioral goals. The participants' application usage, behavioral changes, and body weight were assessed after 3 months, with health checkup data evaluated after 1 year. Results: The proportion of mHealth application users after 3 months was significantly higher in the intervention group (68.4%) than in the control group (40.0%). The intervention group also reported a significantly greater weekly frequency of mHealth application usage. Moreover, the intervention group reported a significantly decreased change in triglyceride levels after 1 year compared with the control group. Conclusions: Recommending commercially available mHealth applications in a health guidance setting significantly increased the number of mHealth application users and their frequency of use.

• Access to Document (DOI)

Association of Social Participation with Cardiovascular Risk Factors: A Systematic Review.

Miura M, Ikeda A, Sato S, Muraki I, Okamura T, Ohira T, Miyazaki J, Ishihara M, Okamoto K, Kamijima J, Li Q, Ikeda S, Yamagishi K, Tanigawa T

Journal of atherosclerosis and thrombosis 32 （ 8 ） 897 - 910 2025年05月

ISSN  1340-3478

　概要を見る

Aim: Although social participation, defined as involvement in social activities, may be beneficial for cardiovascular health, evidence about the association remains limited. This systematic review summarized the relationship between social participation and cardiovascular risk factors. Methods: Original articles of longitudinal observational studies published in English before January 1, 2024, were searched via PubMed, Scopus, and Cochrane Library. Two investigators selected eligible literature for four health outcomes: hypertension, diabetes, dyslipidemia, and obesity. Results: Eight articles (including duplicates) covering cohort studies were included. The results indicated that social participation is associated with lower hypertension risk, but gender differences may exist in the association between social participation and hypertension. Two articles from a Japanese cohort study were found on diabetes, both of which reported significant preventive association with social participation. The only study on dyslipidemia showed a higher hyperlipidemia risk among women, but not men, with social participation. Two studies on the risk of obesity showed inconsistent results, with one reporting the association between social participation and maintenance of smaller waist circumference only among men, while the other found no association with body mass index. Conclusions: There is some evidence of the association between social participation and better cardiovascular health outcomes. However, evidence on gender differences and validation of the methodology for measuring social participation was still lacking.

• Access to Document (DOI)

Serum Total Cholesterol and Fatal Subarachnoid Hemorrhage in 120,000 Japanese: A Pooled Analysis of Data from 12 Cohorts.

Satoh A, Arima H, Tanaka-Mizuno S, Fujiyoshi A, Kadota A, Miura K, Ueshima H, Okamura T, Murakami Y, EPOCH JAPAN Research Group

Journal of atherosclerosis and thrombosis 32 （ 11 ） 1425 - 1433 2025年05月

ISSN  1340-3478

　概要を見る

Aim: The aim of this study was to clarify the association between serum total cholesterol and fatal subarachnoid hemorrhage in Japanese men and women. Methods: The study involved a pooled analysis of individual data from 12 well-qualified cohort studies conducted in Japan. The participants were classified according to their serum total cholesterol levels: ＜4.14 mmol/L (＜160 mg/dL), 4.14–4.64 mmol/L (160–180 mg/dL), 4.65–5.16 mmol/L (180–199 mg/dL), 5.17–5.68 mmol/L (200–219 mg/dL), 5.69–6.20 mmol/L (220–239 mg/dL), and ≥ 6.21 mmol/L (≥ 240 mg/dL). The outcome of the analysis was death from subarachnoid hemorrhage. Results: A total of 120,973 participants (70,947 women and 50,026 men) aged 18–96 years at baseline underwent follow-up for a median of 12.7 years, and 261 participants died from subarachnoid hemorrhage during this period. In women, both low (＜5.69 mmol/L [＜220 mg/dL]) and high (≥ 6.21 mmol/L [≥ 240 mg/ dL]) serum total cholesterol levels were significantly associated with a higher risk of fatal subarachnoid hemorrhage compared with the reference group (5.69–6.20 mmol/L [220–239 mg/dL]). These associations remained significant after adjustment for confounding factors. In contrast, no associations were observed in men. Conclusion: Both low and high serum total cholesterol levels were associated with a higher risk of fatal subarachnoid hemorrhage in 70,947 female participants from 12 cohort studies throughout Japan.

• Access to Document (DOI)